Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials. (2025). SKIN The Journal of Cutaneous Medicine, 9(1), s520. https://doi.org/10.25251/skin.9.supp.520